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a b s t r a c t
We previously discovered that nuclear import of high risk HPV16 E7 is mediated by a cNLS located within
the zinc-binding domain via a pathway that is independent of karyopherins/importins (Angeline et al.,
2003; Knapp et al., 2009). In this study we continued our characterization of the cNLS and nuclear import
pathway of HPV16 E7. We ﬁnd that an intact zinc-binding domain is essential for the cNLS function in
mediating nuclear import of HPV16 E7. Mutagenesis of cysteine residues to alanine in each of the two
CysXXCys motifs involved in zinc-binding changes the nuclear localization of the EGFP-16E7 and 2xEGFP-
16E7 mutants. We further discover that a patch of hydrophobic residues, 65LRLCV69, within the zinc-
binding domain of HPV16 E7 mediates its nuclear import via hydrophobic interactions with the FG
domain of the central channel nucleoporin Nup62.
& 2013 Elsevier Inc. All rights reserved.
Introduction
Human Papillomaviruses (HPVs) are estimated to be the most
common sexually transmitted infection in the United States. The
largest group of HPVs is the alpha HPVs, and consists of both
cutaneous viruses causing common warts, as well as the approxi-
mately 40 mucosal types known to infect the cervical epithelium.
Mucosal HPVs are further divided into high and low risk groups,
dependent upon the frequency with which they have been linked
to the malignant progression of their resultant lesions (Doorbar,
2006; zur Hausen, 2000, 2009). Fifteen of the sexually transmitted
genital HPVs can be classiﬁed as high risk, notably HPV16, HPV18,
HPV31, HPV33 and HPV45, which may result in squamous intrae-
pithelial lesions capable of progressing to invasive carcinomas
(Doorbar, 2006; Munger et al., 2004; zur Hausen, 2000, 2009).
Nearly 99% of cervical cancers and 20% of oropharynx cancers are
positive for high risk HPV DNA, with HPV16 found in nearly 63% of
the cervical cancers (Doorbar, 2006).
HPVs are dependent on the replication machinery of the host
cells and consequently they have evolved the E7 oncoproteins to
induce reentry into the S phase of the differentiated epithelial cells
and establish the appropriate environment required to support viral
DNA ampliﬁcation. To accomplish this, the high risk HPV16/18 E7
oncoproteins bind and destabilize the retinoblastoma protein (pRB)
and the RB-related pocket proteins, p130 and p107. E7 oncoproteins
interact also with other components of the cell cycle machinery, such
as cyclin A, cyclin E and the cyclin-dependent kinase inhibitors p27
and p21 (Jones and Munger,1996; Zwerschke and Jansen-Durr, 2000;
McLaughlin-Drubin and Munger, 2009). In addition to these nuclear
target proteins, HPV16 E7 binds to targets in the cytoplasm, such as
the microtubule-associated N-end rule ubiqutin ligase p600 (Huh
et al., 2005) and the nuclear mitotic apparatus protein (NuMA)
(Nguyen and Munger, 2009).
Structurally, the E7 proteins consist of three biochemically
distinct domains. Both NMR and X-ray crystal structures have
been solved for the C terminal domain of E7, and the three-
dimensional structure has been shown to organize into a tightly
packed zinc-binding fold (McLaughlin-Drubin and Munger, 2009).
The N terminus conserved regions (CR) CR1 (aa1–15) and CR2
(aa16–37) of HPV16 E7 possess signiﬁcant sequence similarity to a
portion of CR1 and the entirety of CR2 of adenovirus E1A and
related sequences of SV40 large tumor antigen, as well as func-
tional similarity, contributing to the transforming ability of HPV16
E7. The CR2 domain contains both the Leu–X–Cys–X–Glu (LxCxE)
pRB binding motif as well as a consensus casein kinase II (CKII)
phosphorylation site. The C-terminal CR3 domain (aa38–98) con-
tains a zinc-binding domain with two Cys–X–X–Cys motifs sepa-
rated by 29 amino acids (McLaughlin-Drubin and Munger, 2009).
High risk HPV16 E7 is predominantly nuclear in the CaSki
cervical carcinoma cell line, when expressed transiently in HaCaT
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and U2OS cells, and in invasive cervical carcinoma (Guccione et al.,
2002; Fiedler et al., 2004; Cid-Arregui et al., 2003). We have
previously discovered that nuclear import of HPV16 E7 and HPV11
E7 is mediated by a Ran-dependent pathway that is independent
of karyopherins/importins and it is mediated by their cNLS located
within the unique zinc-binding domain (Angeline et al., 2003; Knapp
et al., 2009; Piccioli et al., 2010). Both HPV16 E7 and HPV11 E7
proteins have also a leucine-rich nuclear export signal (NES) located
within the zinc-binding domain that mediates their nuclear export
via a CRM1 pathway (Knapp et al., 2009; McKee et al., 2013).
Nuclear import and export of different cargoes take place
through nuclear pore complexes (NPCs) embedded at the nuclear
envelope. There are some 30 nucleoporins (Nups) that assemble to
form the NPC and they can be classiﬁed into: transmembrane
Nups (Poms) that anchor the NPCs at the nuclear envelope,
structural Nups, and FG-Nups containing phenylalanine–glycine
(FG) repeats, and involved in nuclear import and export (Terry and
Wente, 2009). Transport through the NPCs can be via passive
diffusion for cargoes up to approximately 40 kDa, active transport
mediated by karyopherins (importins and exportins) interacting
with FG-Nups for cargoes over 40 kDa, and direct interaction of
some cargoes with FG-Nups bypassing the requirement for kar-
yopherins (Terry and Wente, 2009). The central channel for
nucleocytoplasmic transport consists of three nucleoporins,
Nup62, Nup58 and Nup54 and the structures of the Nup62–
Nup54 and Nup54–Nup58 interacting domains has been recently
determined revealing the architecture of the mammalian transport
channel (Solmaz et al., 2011).
In this study we continue our characterization of the cNLS and
nuclear import pathway of high risk HPV16 E7 oncoprotein. We
determine that an intact zinc-binding domain within the CR3
domain is essential for the cNLS function in mediating nuclear
import of HPV16 E7. Mutagenesis of Cys residues in each of the
two CysXXCys motifs involved in zinc binding changes the nuclear
localization of the resultant EGFP-16E7 and 2xEGFP-16E7 mutants.
We further discover that a patch of hydrophobic residues,
65LRLCV69, within the zinc-binding domain of HPV16 E7 mediates
its nuclear import via direct hydrophobic interactions with the FG
domain of the channel nucleoporin, Nup62.
Results
The zinc-binding domain of HPV16 E7 is essential
for its nuclear localization
We have previously established the presence of a C-terminal
NLS in the CR3 domain of HPV16 E7 containing the zinc-binding
fold that consists of two copies of a Cys–X–X–Cys motif separated
by 29 amino acids (Knapp et al., 2009). Moreover, we have
determined that the zinc-binding domain of HPV11 E7 is essential
for its nuclear import and localization (Piccioli et al., 2010). To
examine the possibility that the intact zinc-binding domain of
HPV16 E7 is essential for the nuclear import activity of the cNLS of
HPV16 E7, we have now performed site-directed mutagenesis of
cysteine residues in each of the two copies of Cys–X–X–Cys in the
context of EGFP-16E7 and 2xEGFP-16E7 generating the CC58/59AA
and C91A mutants. The CC58/59AA mutant is designated CC58AA
for simplicity. HeLa cells were transiently transfected with the
wild type EGFP-16E7, the EGFP-16E7CC58AA and EGFP-16E7C91A
cysteine mutants and EGFP control, and the cellular localization
of the expressed proteins was examined via confocal ﬂuorescence
microscopy. As previously reported, the wild type EGFP-16E7 had a
nuclear localization in the majority of transfected cells with the
rest of cells having a pancellular phenotype (Fig. 1); EGFP had a
pancellular localization in all the transfected cells (Fig. 1). Both the
EGFP-16E7CC58AA and EGFP-16E7C91A cysteine mutants exhibited a
pancellular localization, similar with that of EGFP, in the majority
of transfected cells, 83.2%74.1%, and 85.8%76.9% respectively
(Fig. 1). These data indicate that, while disruption of the zinc-
binding domain in the context of EGFP-16E7 led to a change in the
localization from mostly nuclear to pancellular, it did not com-
pletely prevent the EGFP-16E7CC58AA or EGFP-16E7C91A mutants
from gaining some entry to the nucleus. As the cysteine mutations
can affect the dimerization of 16E7, and in the absence of
dimerization the EGFP-16E7CC58AA and EGFP-16E7C91A mutants
could enter by passive diffusion (as the EGFP itself), we generated
the same mutants in the context of 2xEGFP-16E7 (containing a
2xEGFP module) to exceed the limit for passive diffusion across
the nuclear pore complex. HeLa cells were transiently transfected
with the 2xEGFP-16E7CC58AA and 2xEGFP-16E7C91A mutants, along
with the 2xEGFP-16E7 wild type and 2xEGFP control. As pre-
viously reported the 2xEGFP-16E7 wild type had a predominantly
nuclear localization in the majority of cells (Figs. 1 and 2, panels B
and C) and 2xEGFP had a cytoplasmic localization (Figs. 1 and 2,
panels K and L). Signiﬁcantly, the 2xEGFP-16E7CC58AA and 2xEGFP-
16E7C91A, exhibited predominantly cytoplasmic localization in the
majority of transfected cells, 86.4%73.6% and 89.8%75.1%,
respectively (Figs. 1 and 2, panels E, F, H and I). Together these
data support the conclusion that the nuclear import activity of the
cNLS of HPV16 E7 is dependent upon an intact zinc-binding
domain. The loss of zinc coordination in the cysteine mutants
can lead to structural changes in the zinc-binding domain that
would make unavailable the critical residues of the cNLS.
We have previously showed that a cysteine residue at position 59
-conserved between the high risk and low risk HPVs, and not
involved in coordinating the zinc ion – plays some role in the cNLS
function of HPV11 E7 (Piccioli et al., 2010). To examine if this
conserved cysteine residue performs a similar function in HPV16 E7,
site directed mutagenesis was used to generate a pair of single amino
acid substitutions of the N-terminal cysteines within the zinc-binding
domain in the context of 2xEGFP-16E7. The 2xEGFP-16E7 wild type,
2xEGFP-16E7 single cysteine mutants and 2xEGFP, were transiently
transfected into HeLa cells and their resultant subcellular localizations
were examined via confocal ﬂuorescence microscopy. Both 2xEGFP-
16E7 wild type and 2xEGFP-16E7C59A exhibited predominantly
nuclear localization (Fig. 3A, panels B and C; and panels H and I),
Fig. 1. Quantitative analysis of the effect of mutations of the zinc coordinating
cysteine residues to alanine on the nuclear localization of EGFP-16E7 and 2xEGFP-
16E7. Data from ﬁve experiments using EGFP-16E7, EGFP-16E7CC58AA, EGFP-
16E7C91A, EGFP, 2xEGFP-16E7, 2xEGFP-16E7CC58AA, 2xEGFP-16E7C91A, and 2xEGFP
plasmids were used for quantitative analysis and graphic representation of the
localization distribution of transfected HeLa cells. Black bars represent cells
exhibiting predominant nuclear localization; gray bars represent cells exhibiting
pancellular localization; white bars represent cells exhibiting predominant cyto-
plasmic localization.
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although at reduced levels for the 2xEGFP-16E7C59A mutant (57.3%
711.1%) (Fig. 3B). In contrast, the 2xEGFP-16E7C58A exhibited pre-
dominantly pancellular localization (Fig. 3A, panels E and F) in 66.3%
718.6% cells and also cytoplasmic localization in 28.8%718.8% cells
(Fig. 3B). In the context of 1xEGFP, the reductions in nuclear
localization caused by the C58A and C59A mutations were more
modest. EGFP-16E7C58A and EGFP-16E7C59A were predominantly
nuclear in 55.3%75.7% and 69.3%79.5% transfected cells with the
rest of cells exhibiting a pancellular phenotype (Fig. 3B); this is in
comparisonwith 85%72.4% cells showing nuclear localization for the
EGFP-16E7 wild type (Fig. 3B). Immunoblot analyses of the expressed
EGFP-16E7, 2xEGFP-16E7 and the different cysteine mutants per-
formed with a GFP antibody indicated that the wild type and mutant
proteins were expressed properly at similar levels (Fig. 4). These data
suggest that cysteine 59 can partially compensate for the loss of
cysteine 58 in coordinating the zinc ion and maintaining the zinc-
binding domain and nuclear localization, and also that cysteine 59
may play a very modest role in the cNLS function.
Fig. 2. Mutation of the zinc coordinating cysteine residues to alanine changes the nuclear localization of 2xEGFP-16E7. HeLa cells were transfected with either 2xEGFP-16E7
wild type (panels A–C), 2xEGFP-16E7CC58AA (panels D–F), 2xEGFP-16E7C91A (panels G–I), or 2xEGFP (panels J–L) plasmids and examined by confocal ﬂuorescence microscopy
at 24 h post transfection. Panels A, D, G and J represent the DAPI staining of the nuclei, panels B, E, H and K represent the ﬂuorescence of the EGFP and panels C, F, I, and L
represent the merge.
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Fig. 3. A. Single cysteine substitution to alanine within the zinc ﬁnger alters the nuclear localization of 2xEGFP-16E7. HeLa cells were transfected with either 2xEGFP-16E7
wild type (panels A–C), 2xEGFP-16E7C58A (panels D–F), 2xEGFP-16E7C59A (panels G–I), or 2xEGFP (panels J–L) plasmids and examined by confocal ﬂuorescence microscopy at
24 h post-transfection. Panels A, D, G and J show the DAPI staining of the nuclei, panels B, E, H and K represent the ﬂuorescence of the EGFP and panels C, F, I, and L represent
the merge. B. Quantitative analysis of the effect of single cysteine substitution within the zinc ﬁnger on the localization of EGFP-16E7 and 2xEGFP-16E7. Data from ﬁve
experiments using EGFP-16E7, EGFP-16E7C58A, EGFP-16E7C59A, EGFP, 2xEGFP-16E7, 2xEGFP-16E7C58A, 2xEGFP-16E7C59A, and 2xEGFP plasmids were used for quantitative
analysis and graphic representation of the localization distribution of transfected HeLa cells. Black bars represent cells exhibiting predominant nuclear localization; gray bars
represent cells exhibiting pancellular localization; white bars represent cells exhibiting predominant cytoplasmic localization.
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A hydrophobic patch within the zinc-binding domain is essential
for the nuclear localization of HPV16 E7
The surface hydrophobicity of karyopherins/importins is sufﬁ-
cient to provide access to the NPC and translocation is achieved
through a series of non-speciﬁc interactions between short hydro-
phobic patches on the surface of the karyopherins and the FG-
Nups within the NPC (Naim et al., 2009). We have previously
identiﬁed a small hydrophobic patch of amino acids, 65VRLVV69,
within the zinc-binding domain of HPV11 E7 that was required for
its nuclear localization (McKee et al., 2013). A small hydrophobic
patch within the zinc-binding domain of HPV16 E7, 65LRLCV69, has
signiﬁcant homology to the patch previously characterized in
HPV11 E7, 65VRLVV69 (McKee et al., 2013). To examine the
possibility that this hydrophobic patch of amino acids within the
zinc-binding domain of HPV16 E7 is required for mediating its
nuclear import we used site-directed mutagenesis to replace all
ﬁve amino acids with alanine and generated the LRLCV65-
69AAAAA mutation in the context of 2xEGFP-16E7 and GST-
16cE7. The LRLCV65-69AAAAA mutation is designated LRLCV65-
AAAAA, again for simplicity. We also generated single mutants by
substituting the arginine at position 66 with alanine in the context
of 2xEGFP-16E7 and GST-16cE7.
HeLa cells were transiently transfected with the 2xEGFP-
16E7LRLCV65AAAAA and 2xEGFP-16E7R66A mutants, along with the
2xEGFP-16E7 wild type and 2xEGFP and the localization of the
resultant proteins was examined via confocal ﬂuorescence micro-
scopy. As previously shown the 2xEGFP-16E7 wild type was
nuclear in the majority of cells (Fig. 5A, panels E and I; and
Fig. 5B) whereas the 2xEGFP was cytoplasmic in all the transfected
cells (Fig. 5A, panels H and L; and Fig. 5B). In contrast with the
nuclear localization of the wild type, the 2xEGFP-16E7LRLCV65AAAAA
mutant was cytoplasmic in 84.9%74.3% of transfected cells, with
the rest of cells having a pancellular localization (Fig. 5A, panels F
and J; and Fig. 5B). The 2xEGFP-16E7R66A mutant had a similar
nuclear localization as the wild type in the majority of cells (86.2%
74.2%) (Fig. 5A, panels G and K; and Fig. 5B). In the context of
EGFP-16E7, 84.8%74.2% of EGFP-16E7LRLCV65AAAAA expressing cells
exhibited a pancellular phenotype similarly as the EGFP itself
(Fig. 5C), whereas 92.3%72.6% of EGFP-16E7R66A expressing cells
exhibited a predominantly nuclear phenotype (Fig. 5C). Together
these data suggest that these hydrophobic residues, 65LRLCV69, are
responsible for the nuclear localization of 2xEGFP-16E7 and EGFP-
16E7 whereas the positively charged arginine 66 residue plays no
signiﬁcant role in the function of the cNLS. To ensure that the
results observed were not due to degradation of the mutants,
immunoblot analysis with an anti-GFP antibody was performed.
The data indicate that all the 2xEGFP-16E7 and EGFP-16E7 mutant
proteins were expressed at the correct molecular weight and at
similar levels with their corresponding wild type proteins;
although the 2xEGFP-16E7 mutants show a certain level of
proteolytic degradation, it is at the same level as for the 2xEGFP-
16E7 wild type (Fig. 5D).
To further conﬁrm this conclusion drawn from the transient
transfection experiments in HeLa cells, in vitro nuclear import
assays were performed using the same mutants in the context of
GST-16cE7. In these experiments, digitonin permeablized HeLa
cells were incubated with GST-16cE7, GST-16cE7LRLCV65AAAAA, GST-
16cE7R66A, GST-M9 as a positive control, or GST as a negative
control, in the presence of either transport buffer or HeLa cytosol.
Detection of the GST fusion proteins was via immunoﬂuorescence
staining with a speciﬁc GST antibody and subsequent examination
by confocal ﬂuorescence microscopy. As expected, both GST-16cE7
and GST-M9 were imported into the nucleus in the presence of
HeLa cytosol (Fig. 6, panels G and F). In agreement with the
previous transfection data the GST-16cE7LRLCV65AAAAA hydrophobic
mutant was no longer imported into the nucleus, whereas the
GST-16cE7R66A was imported into the nucleus in the presence of
cytosol (Fig. 6, panels H and I). As expected, no nuclear import was
observed for the GST negative control (Fig. 6, panel J). Together
these data support the previous conclusion that the hydrophobic
residues, 65LRLCV69, within the zinc-binding domain of HPV16 E7
are essential for the cNLS function and that the charged arginine
residue at position 66 has no signiﬁcant role in nuclear import.
HPV16 E7 interacts via its zinc-binding domain with the FG domain
of Nup62
The mechanism by which hydrophobic residue patches of
karyopherins mediate nuclear import is through non-speciﬁc
hydrophobic interactions with the FG repeats in nucleoporins
(Terry and Wente, 2009). To examine the possibility that the
hydrophobic patch of HPV16 E7, 65LRLCV69, mediates nuclear
import through direct non-speciﬁc interactions with FG-Nups we
performed isolation assays. For these experiments we chose the FG
nucleoporin Nup62 because it is located at the central transport
channel of the NPC and interacts with karyopherins/importins
mediating nucleocytoplasmic trafﬁc of cargoes (Solmaz et al.,
2011). Nup62 forms triple helices with Nup54 that project alter-
natively up and down from either side of the midplane Nup54–
Nup58 ring, and constitute cytoplasmic and nucleoplasmic entries
for nuclear import and export complexes via their N-terminal FG
domains (Solmaz et al., 2011). In these experiments we used GST-
Nup62N, containing all six FG repeats of Nup62, and GST, as a
negative control. These GST fusion proteins were immobilized on
glutathione–Sepharose beads and incubated with HeLa cell lysates
expressing EGFP-16E7 wild type, EGFP-16E7LRLCV65AAAAA, EGFP-
16E7R66A, or EGFP. The bound proteins were then eluted and
analyzed via immunoblotting with a GFP antibody. As a positive
control for binding to Nup62N we used Kap β2/transportin. The
positive control, Kap β2 bound to GST-Nup62N (Fig. 7, lane 10) but
not to GST itself (Fig. 7, lane 15), whereas the negative control
EGFP did not bind to either one (Fig. 7, lanes 9 and 14).
Fig. 4. The EGFP-16E7 and 2xEGFP-16E7 cysteine mutants are properly expressed
in HeLa cells. HeLa cells were transfected with EGFP-16E7 (lane 1), EGFP-16E7C58A
(lane 2), EGFP-16E7C59A (lane 3), EGFP-16E7CC58AA (lane 4), EGFP-16E7C91A (lane 5),
EGFP (lane 6), 2xEGFP-16E7 (lane 7), 2xEGFP-16E7C58A (lane 8), 2xEGFP-16E7C59A
(lane 9), 2xEGFP-16E7CC58AA (lane 10), 2xEGFP-16E7C91A (lane 11), or 2xEGFP (lane
12) plasmids. Cell lysates were prepared 24 h post transfection and probed with a
GFP antibody.
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Fig. 5. A. Mutation of hydrophobic residues within the zinc-binding domain disrupts the nuclear localization of 2xEGFP-16E7. HeLa cells were transfected with either
2xEGFP-16E7 wild type (panels A, E, and I), 2xEGFP-16E7LRLCV65AAAAA (panels B, F, and J), 2xEGFP-16E7R66A (panels C, G, and K), or 2xEGFP (panels D, H, and L) plasmids and
examined by confocal ﬂuorescence microscopy at 24 h post-transfection. Panels A–D represent DAPI staining of the nuclei, panels E–H represent EGFP ﬂuorescence, and
panels I–L represent the merge. B. Quantitative analysis of the effect of mutation of hydrophobic residues within the zinc-binding domain on the localization of 2xEGFP-16E7
in HeLa cells. Data from seven experiments using 2xEGFP-16E7 wild type, 2xEGFP-16E7LRLCV65AAAAA, 2xEGFP-16E7R66A, and 2xEGFP plasmids were used for quantitative
analysis and graphic representation of the localization distribution of transfected HeLa cells. Black bars represent cells exhibiting predominant nuclear localization; gray bars
represent cells exhibiting pancellular localization; white bars represent cells exhibiting predominant cytoplasmic localization. C. Quantitative analysis of the effect of
mutation of hydrophobic residues within the zinc-binding domain on the localization of EGFP-16E7 in HeLa cells. Data from ﬁve experiments using EGFP-16E7 wild type,
EGFP-16E7LRLCV65AAAAA, EGFP-16E7R66A, and EGFP plasmids were used for quantitative analysis and graphic representation of the localization distribution of transfected HeLa
cells. Black bars represent cells exhibiting predominant nuclear localization; gray bars represent cells exhibiting pancellular localization; white bars represent cells exhibiting
predominant cytoplasmic localization. D. EGFP-16E7 and 2xEGFP-16E7 hydrophobic residues and R66A mutants are properly expressed in HeLa cells. HeLa cells were
transfected with 2xEGFP-16E7 (lane 1), 2xEGFP-16E7LRLCV65AAAAA (lane 2), 2xEGFP-16E7R66A (lane 3), 2xEGFP (lane 4), EGFP-16E7 (lane 5), EGFP-16E7LRLCV65AAAAA (lane 6),
EGFP-16E7R66A (lane 7), or EGFP (lane 8) plasmids. Cell lysates were prepared 24 h post transfection and probed with a GFP antibody.
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Signiﬁcantly, the results show that both EGFP-16E7 wild type and
EGFP-16E7R66A interacted with GST-Nup62N (Fig. 7, lanes 6 and 8),
but not with GST (Fig. 7, lanes 11 and 13, respectively). This
correlates well with the previously observed nuclear localization
of both EGFP-16E7 and EGFP-16E7R66A. Signiﬁcantly, the EGFP-
16E7LRLCV65AAAAA hydrophobic residue mutant failed to interact
with GST-Nup62N (Fig. 7, lane 7). We also performed isolation
assays with GST-Nup62C, representing the C-terminal domain of
Nup62 lacking any FG repeats, and neither Kap β2 nor EGFP-16E7
bound to GST-Nup62C (data not shown). Taken together, these
data strongly suggest that the patch of hydrophobic residues,
65LRLCV69, within the zinc-binding domain of HPV16 E7 is
essential for the cNLS function through the interaction with the
FG repeats in Nup62, and that the charged arginine residue at
position 66 has no role in this process.
Interestingly, an HPV16 E7 mutant containing a mutation in this
mostly hydrophobic patch L67R, although retaining its ability to bind
pRb, is defective in abrogating pRB-mediated cell cycle arrest and fails
to bind HDAC (Avvakumov et al., 2003; Brehm et al., 1999). To
examine if this L67R mutation within 65LRLCV69 interferes with the
nuclear localization of HPV16 E7 we introduced this mutation both in
the context of EGFP-16E7 and 2xEGFP-16E7 and analyzed their
localization in comparison with the wild type proteins. In contrast
with the nuclear localization of EGFP-16E7 and 2xEGFP-16E7 (Fig. 8A,
panels A and I; panels C and K; and Fig. 8B), the EGFP-16E7L67R had a
pancellular localization in 85.870.9% of transfected cells (Fig. 8A,
panels B and J; and Fig. 8B), whereas the 2xEGFP-16E7L67R had a
cytoplasmic localization in 76.872.5% of cells and a pancellular
localization in the rest of cells (Fig. 8A, panels D and L; and Fig. 8B).
Immunoblot analysis with an anti-GFP antibody indicated that EGFP-
16E7L67R and 2xEGFP-16E7L67R mutant proteins were expressed at the
correct molecular weight and at similar levels with their correspond-
ing wild type proteins (Fig. 8C). These results indicate that the
hydrophobic leucine 67 residue is essential for the nuclear localization
of 16E7 and its substitution with the positively charged arginine
residue leads to a loss of nuclear import function of the cNLS.
There is another HPV16 E7 mutant that partially overlaps with the
65LRLCV69 hydrophobic patch, CVQ68-70AAA, that has a mixed
phenotype: it has wild type activity regarding the ability to block
binding of pRb to E2F and to destabilize pRb (Helt and Galloway,
2001), and to bind to p600 and E2F6 (Huh et al., 2005; McLaughlin-
Drubin et al., 2008); however, the CVQ68-70AAA mutant fails to
bypass DNA damage checkpoints, to extend HFK lifespan, to inactivate
p21 and to bind to cullin 2 ubiquitin ligase complex (Helt and
Galloway, 2001; Helt et al., 2002; Huh et al., 2007; Roman and
Munger, 2013). We generated the 2xEGFP-16E7CVQ68AAA mutant and
analyzed its localization in comparison with the wild type and found
that the CVQ68-70AAA mutation caused a change in the localization
from nuclear in the majority of cells (85.65%77.2%) for the wild type
to pancellular in 61.83%74.4% of cells and cytoplasmic in 35.73%
74.17% cells for the mutant (Fig. 9A). These data indicate that
substitution of the last two residues in the hydrophobic patch, cysteine
and valine, to alanine leads to signiﬁcant weakening of the cNLS
nuclear import function.
Fig. 6. Mutation of hydrophobic residues within the zinc-binding domain inhibits nuclear import of GST-16cE7. Digitonin-permeabilized HeLa cells were incubated with
GST-M9 (panels A and F), GST-16cE7 (panels B and G), GST-16cE7LRLCV65AAAAA (panels C and H), GST-16cE7R66A (panels D and I), or GST (panels E and J) in the presence of only
transport buffer (panels A–E) or HeLa cytosol and energy mix (panels F–J).
Fig. 7. HPV16 E7 interacts with the FG domain of Nup62 and mutations of
hydrophobic residues within the zinc-binding domain disrupt this interaction.
HeLa cells were transfected with EGFP-16E7, EGFP-16E7LRLCV65AAAAA, EGFP-
16E7R66A, and EGFP plasmids. Cell lysates were prepared 24 h post transfection
and probed with either a GFP antibody (lane 1, EGFP-16E7; lane 2, EGFP-
16E7LRLCV65AAAAA; lane 3, EGFP-16E7R66A; lane 4, EGFP) or Kap β2 antibody (lane
5). GST-Nup62N (lanes 6-10) and GST (lanes 11–15) immobilized on glutathione–
Sepharose were incubated with the cell lysates and the bound proteins were eluted
and analyzed via immunoblotting with a GFP antibody (lanes 6 and 11, EGFP-16E7;
lanes 7 and 12, EGFP-16E7 LRLCV65AAAAA; lanes 8 and 13, EGFP-16E7R66A; and lanes
9 and 14, EGFP). Binding of Kap β2 to GST-Nup62N and GST was detected with a
Kap β2 antibody (lanes 10 and 15).
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Fig. 8. The L67R mutation disrupts the nuclear localization of EGFP-16E7 and 2xEGFP-16E7. A. HeLa cells were transfected with EGFP-16E7 (panels A, E and I), EGFP-16E7L67R
(panels B, F and J), 2xEGFP-16E7 (panels C, G and K), or 2xEGFP-16E7L67R (panels D, H and L) plasmids, and the localization of the expressed proteins was analyzed by
confocal ﬂuorescence microscopy. Panels A–D represent the ﬂuorescence of the EGFP, panels E-H the DAPI staining of the nuclei, and panels I–L the merge. B. Quantitative
analysis of the effect of L67R mutation on the localization of EGFP-16E7 and 2xEGFP-16E7. Data from four experiments using EGFP-16E7 wild type, EGFP-16E7L67R, 2xEGFP-
16E7 wild type and 2xEGFP-16E7L67R plasmids were used for the quantitative analysis and graphic representation of the localization distribution of transfected HeLa cells.
Black bars represent cells showing predominant nuclear localization; gray bars represent cells showing pancellular localization; white bars represent cells showing
predominant cytoplasmic localization. C. EGFP-16E7L67R and 2xEGFP-16E7L67R mutants are properly expressed in HeLa cells. HeLa cells were transfected with EGFP-16E7
(lane 1), EGFP-16E7L67R (lane 2), EGFP (lane 3), 2xEGFP-16E7 (lane 4), 2xEGFP-16E7L67R (lane 5) and 2xEGFP (lane 6). Cell lysates were prepared 24 h post transfection and
probed with a GFP antibody.
J. Eberhard et al. / Virology 446 (2013) 334–345 341
Discussion
In this study we continued our analysis of the nuclear import
pathway and characterization of the cNLS of high risk HPV16 E7
using both transfection assays in HeLa cells with EGFP fusions
containing 16E7 and different mutants and nuclear import assays
in digitonin-permeabilized HeLa cells with GST fusions to the CR3
of 16E7. The CR3 domain contains a zinc-binding domain that
consists of two Cys–X–X–Cys motifs separated by 29 amino acids
that is conserved between the high and low risk HPV types
(McLaughlin-Drubin and Munger, 2009). The integrity of this
zinc-binding domain has been shown to be necessary for dimer-
ization and, in high risk HPV types, the transformative capacity of
E7 (McLaughlin-Drubin and Munger, 2009). Here we presented
data showing that mutations of Cys residues in the two Cys–X–X–
Cys motifs that affect the zinc binding clearly disrupt the nuclear
localization of the resultant EGFP-16E7 and 2xEGFP-16E7 mutants.
These data strongly suggest that the integrity of the zinc-binding
Fig. 9. A. Analysis of the effect of CVQ68AAA mutation on the nuclear localization of 2xEGFP-16E7. HeLa cells were transfected with 2xEGFP-16E7 (panels A, B and C) or
2xEGFP-16E7CVQ68AAA (panels D, E and F) plasmids, and the localization of the expressed proteins was analyzed by confocal ﬂuorescence microscopy. Panels A and D
represent the ﬂuorescence of the EGFP, panels B and E the DAPI staining of the nuclei, and panels C and F the merge. B. The 2xEGFP-16E7CVQ68AAA mutant is expressed
properly in HeLa cells. HeLa cells were transfected with 2xEGFP-16E7 (lane 1), 2xEGFP-16E7CVQ68AAA (lane 2) and 2xEGFP (lane 3). Cell lysates were prepared 24 h post
transfection and probed with a GFP antibody.
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domain of HPV16 E7 is critical for the nuclear import activity of
the cNLS, in addition to the requirement for dimerization and
transformation potential. The cysteine residues involved in zinc
coordination within the CR3 domain of E7 proteins are the most
highly conserved cysteine residues among the different HPV types
and we have previously established for the low risk HPV11 E7 that
the integrity of its zinc-binding domain is essential for the nuclear
import activity of the cNLS (Piccioli et al., 2010). The loss of zinc
coordination can lead to structural changes of the CR3 domain that
would make unavailable the critical hydrophobic residues of the
cNLS. In addition, another viral protein, the TAX protein of human
T lymphotropic virus type 1 (HTLV-1), also enters the nucleus via a
pathway mediated by its zinc-binding domain (Tsuji et al., 2007).
Our previous studies have shown that nuclear entry of HPV16
E7 is mediated by its unique cNLS using a pathway that it is
independent of karyopherins/importins (Angeline et al., 2003;
Knapp et al., 2009). One possible mechanism that bypasses the
requirement of nuclear import receptors is via direct low afﬁnity
hydrophobic interactions between E7 and the phenylalanine–
glycine (FG) repeats in FG nucleoporins in a manner similar to
that used by traditional receptors/karyopherins. Signiﬁcantly,
the zinc-binding domain of HPV16 E7 is very rich in nonpolar
hydrophobic residues, with some of them arranged in small
hydrophobic patches, suggesting a similar mechanism for how the
zinc-binding domain of HPV16 E7 is able to mediate nuclear
import. In this study we determined that HPV16 E7 interacts via
its zinc-binding domain with the FG repeats domain of Nup62, a
nucleoporin located at the central channel of the NPC and involved
in nuclear import and export of cargoes (Solmaz et al., 2011).
Signiﬁcantly, we found a mostly hydrophobic patch, 65LRLCV69,
within the zinc-binding domain that is essential for the nuclear
localization of EGFP-16E7 and 2xEGFP-16E7. Mutation of the
hydrophobic residues to alanine was sufﬁcient to disrupt the
predominantly nuclear localization of EGFP-16E7 and 2xEGFP-
16E7 and inhibit the nuclear import of GST-16cE7 in digitonin-
permeabilized cells. In contrast, no change in localization was
observed in either the transfection assays, or the nuclear import
assays by mutating the arginine 66 residue to alanine, suggesting
that this positively charged residue has no role in the nuclear
import of HPV16 E7. Signiﬁcantly, mutation of the hydrophobic
residues to alanine inhibited the interaction of HPV16 E7 with the
FG domain of Nup62, suggesting that the hydrophobic residues of
this sequence play a critical role in facilitating the interaction of
the zinc-binding domain of HPV16 E7 with Nup62. Based on the
structure of the zinc-binding domain dimer of HPV1A E7 and the
sequence alignment with other E7 proteins, the 65LRLCV69 patch is
located on the β2 strand and L65, L67 and V69 are highly
conserved hydrophobic residues and may participate in hydro-
phobic interactions that stabilize the dimer (Liu et al., 2006).
Interestingly, an HPV16 E7 L67R mutant, although it binds pRb
in vitro, fails to overcome cell cycle arrest in osteosarcoma cells
in vivo and to transactivate E2F-dependent promoters (Avvakumov
et al., 2003; Brehm et al., 1999). As this L67R mutation within the
hydrophobic patch involved in nuclear import of HPV16 E7
disrupts 16E7 nuclear localization, it can be speculated that this
may contribute to the phenotype of the mutant in vivo. Another
HPV16 E7 mutant, that partially overlaps with the hydrophobic
patch, CVQ68-70AAA, fails to bypass DNA damage checkpoints, to
extend HFK lifespan and to inactivate p21 (Helt and Galloway,
2001; Helt et al., 2002). The CVQ68-70AAA mutation decreases the
nuclear localization and increases the cytoplasmic localization of
16E7, which may contribute to some of its loss of function(s).
The R66A mutant, that retains the nuclear localization of the
wild type, also retains the wild type phenotype, the ability to
destabilize pRb and to bypass DNA damage checkpoints (Helt and
Galloway, 2001).
Overall, the data strongly suggest that the cNLS mediated
nuclear import of HPV16 E7 is via non-speciﬁc hydrophobic
interactions of its zinc-binding domain with the FG repeats
domain of Nup62 at the NPC. The mechanism of nuclear import
of high risk HPV16 E7 oncoprotein is conserved with that of low
risk HPV11 E7 protein (McKee et al., 2013). Nuclear import of
HPV11 E7 is mediated by direct interactions between a homo-
logous hydrophobic patch, 65VRLVV69, within the zinc-binding
domain with the FG domain of Nup62 (McKee et al., 2013). Also,
the cutaneous high risk HPV8 E7 enters the nucleus via hydro-
phobic interactions between a homologous hydrophobic patch,
65LRLFV69, with the FG domain of Nup62 (manuscript in prepara-
tion). It is likely that HPV E7 proteins might interact with other FG
nucleoporins like Nup153 and Nup54 during their translocation
through the NPC into the nucleus.
While the mechanism of nuclear import of HPV E7 oncopro-
teins is conserved between different HPV types, it is unique in
comparison to other HPV proteins, including the L1 and L2 capsid
proteins and the E6 oncoprotein that use different karyopherins to
enter the nucleus (Bordeaux et al., 2006; Darshan et al., 2004;
Klucevsek et al., 2006; Le Roux and Moroianu, 2003; Nelson et al.,
2002). We can only speculate at this time why the HPV E7 proteins
have evolved this nuclear import mechanism independent of
karyopherins, but the relatively small size, the richness in hydro-
phobic residues and the relative low concentration may favor
direct interaction of the E7 proteins with FG nucleoporins and
bypassing the competition for karyopherins. An interesting possi-
bility, that remains to be explored, is that E7 may also function as a
carrier facilitating the nuclear import of a cellular target protein
and changing its nucleocytoplasmic distribution.
Another viral oncoprotein, the TAX protein of HTLV-1 also
enters the nucleus via direct hydrophobic interactions of its zinc-
binding domain with the FG nucleoporin Nup62 at the NPC (Tsuji
et al., 2007). Also, a cellular protein, like PU.1 transcription factor,
enters the nucleus independent of karyopherins via direct binding
to the FG nucleoporins, Nup62 and Nup153 (Zhong et al., 2005).
Materials and methods
Mutagenesis to generate different EGFP-16E7 and 2xEGFP-16E7
mutants
EGFP-16E7 and 2xEGFP-16E7 plasmids were obtained pre-
viously (Knapp et al., 2009). The cysteine mutants EGFP-
16E7C58A, 2xEGFP-16E7C58A, EGFP-16E7CC58AA, 2xEGFP-16E7CC58AA,
EGFP-16E7C91A, 2xEGFP-16E7C91A, EGFP-16E7C59A, and 2xEGFP-
16E7C59A mutants were generated using the QuikChange™ Site-
Directed Mutagenesis Kit (Stratagene) with either EGFP-16E7 or
2xEGFP-16E7 as templates, and the corresponding mutagenesis
primer pairs.
The EGFP-16E7LRLCV65AAAAA, 2xEGFP-16E7LRLCV65AAAAA, EGFP-
16E7R66A, 2xEGFP-16E7R66A, EGFP-16E7L67R, 2xEGFP-16E7L67R and
2xEGFP-16E7CVQ68AAA mutants were generated using the Quik-
Change™ Site-Directed Mutagenesis Kit with either EGFP-16E7 or
2xEGFP-16E7 as templates, and the corresponding mutagenesis
primer pairs.
All mutant plasmids were transformed into XL1-Blue compe-
tent cells (Agilent Technologies), puriﬁed and sequenced for
veriﬁcation (Euroﬁns MWG).
Transient expression of EGFP fusion proteins and confocal microscopy
analysis
HeLa cells (ATCC) were plated on 12 mm poly-L-lysine-coated
glass coverslips to 50% conﬂuency 24 h prior to transfection. Cells
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in each well were transfected with the corresponding EGFP fusion
plasmid (as indicated in the ﬁgure legends) and the FuGENE
6 reagent (Roche Applied Science, IN). Media was changed to
DMEM with 10% FBS and 1% penicillin–streptomycin after 6 h and
the cells were ﬁxed 24 h after the initial transfection with 3.7%
formaldehyde in PBS (10 min). Coverslips were mounted using
Vectashield-DAPI mounting medium (Vector Labs, CA) to visualize
the nuclei by DAPI staining. The slides were examined by confocal
ﬂuorescence microscopy using a Leica TCS Sp5 broadband confocal
microscope and pictures were taken using the Leica LAS AF
software (Leica Microsystems).
Intracellular localization phenotypes of the different EGFP
fusion proteins were scored as predominantly nuclear, pancellular,
or predominantly cytoplasmic, as visually observed via confocal
ﬂuorescence microscopy for each of the transfection experiments.
Data from four to seven experiments (as indicated in the ﬁgure
legends) were used for quantitative analysis. The graphical repre-
sentations for each quantitative analysis display average values
with standard deviations. Immunoblot analyses of the expressed
EGFP-16E7, 2xEGFP-16E7 and different mutants performed with a
GFP antibody indicated that the proteins were expressed at similar
levels and not degraded.
Preparation of GST-16cE7 mutant proteins
The GST-16cE7 plasmid was obtained previously (Knapp et al.,
2009). The GST-16cE7R66A and GST-16cE7LRLCV65AAAAA mutants
were generated using the QuikChange™ Site-Directed Mutagen-
esis Kit with GST-16cE7 as the template, and the mutagenesis
primer pairs as indicated above. The mutant plasmids were
transformed into XL1-Blue competent cells and extracted using
Quantum Preps Plasmid MidiPrep Kit. All puriﬁed plasmids were
sequenced for veriﬁcation (Euroﬁns MWG).
For protein expression and puriﬁcation, each GST-16cE7 plas-
mid was used to transform E. coli BL21 CodonPlus (Agilent
Technologies). Bacteria were then induced with 1 mM IPTG for
3 h at 37 1C, and each mutant protein was puriﬁed in its native
state on glutathione–Sepharose beads (GE Healthcare) using a
standard procedure. The GST-M9 positive control containing the
NLS of hnRNPA1 was also prepared on glutathione–Sepharose
beads using a standard procedure. All puriﬁed GST fusion proteins
were dialyzed in transport buffer (20 mM HEPES-KOH pH 7.3,
110 mM potassium acetate, 2 mMmagnesium acetate, 1 mM EGTA,
and 2 mM DTT) plus the protease inhibitors leupeptin and apro-
tinin. Puriﬁed and dialyzed proteins were aliquoted and stored
at 80 1C. Prior to use, all proteins were checked for purity
and lack of proteolytic degradation by SDS-PAGE and Coomassie
Blue staining.
In vitro nuclear import assays
Nuclear import assays were performed according to previously
established protocols (Angeline et al., 2003; Knapp et al., 2009;
Piccioli et al., 2010). Subconﬂuent HeLa cells, grown on 12 mm
poly-L-lysine coated glass coverslips for 24 h, were permeabilized
with 70 μg/μl digitonin for 5 min on ice to selectively permeabilize
the plasma membrane while leaving the nuclear envelope intact.
As a result, these digitonin-permeabilized cells will retain intact
import-competent nuclei while being largely depleted of cytosolic
transport factors. After three washes with cold transport buffer,
the permeabilized cells were incubated with the import mixture
for 30 min. Each import mixture contained an energy regenerating
system (1 mM GTP, 1 mM ATP, 5 mM phosphocreatine, and 0.4 U
creatine phosphokinase) and the different GST fusion proteins (as
indicated in the ﬁgure legend). In addition, each import contained
either 3 ng/μl BSA in transport buffer, or HeLa cytosol. Final import
reaction volumes were adjusted to 20 μl with transport buffer.
For visualization of nuclear import, the GST fusion proteins
were detected by immunoﬂuorescence with a goat anti-GST anti-
body. Brieﬂy, cells were washed, then ﬁxed with 3.7% formalde-
hyde in PBS for 10 min on ice followed by methanol treatment for
3 min at 20 1C. To reduce non-speciﬁc antibody binding the ﬁxed
cells were blocked for 1 h with 3% BSA/0.1% Tween in PBS. Cells
were then incubated for 1 h with a 1:200 dilution of goat anti-GST
primary antibody and after three washes with 3% BSA/0.1% Tween,
cells were incubated with a 1:100 dilution of FITC conjugated
rabbit anti-goat secondary antibody for 30 min. Following a ﬁnal
three washes, the coverslips were mounted using Vectashield-
DAPI mounting medium to identify the nuclei by DAPI staining.
Nuclear import was assessed by confocal ﬂuorescence microscopy
using a Leica TCS Sp5 broadband confocal microscope and repre-
sentative images were taken using the Leica LAS AF software.
Preparation of GST-Nup62N and GST-Nup62C
The GST-Nup62N (containing aa1–265 of Nup62), and GST-
Nup62C (containing aa178–522 of Nup62) plasmids (Zhong et al.,
2005) were kindly provided by Dr. Nabeel Yaseen. For protein
expression and puriﬁcation the GST-Nup62N, GST-Nup62C and
GST plasmids were used to transform E. coli BL21 CodonPlus. After
induction of the bacteria with 1mM IPTG for 3 h, GST-Nup62N,
GST-Nup62C and GST were puriﬁed in their native state on
glutathione–Sepharose beads using a standard procedure.
Isolation assays
Before performing the binding assays, GST-Nup62N, GST-
Nup62C and GST immobilized on glutathione–Sepharose were
analyzed by SDS-PAGE and Coomassie staining. This analysis
revealed for GST-Nup62N and GST-Nup62C the presence of the
intact protein, and also some degradation. HeLa cell lysates
containing the expressed EGFP-16E7, EGFP-16E7LRLCV65AAAAA,
EGFP-16E7R66A, and EGFP (negative control) were incubated with
GST-Nup62N (containing the FG domain of Nup62), GST-Nup62C
(lacking any FG repeats) or with GST immobilized on glutathione–
Sepharose for 1 h at 4 1C. After washing the beads to remove
nonspeciﬁc binding the bound proteins were analyzed by immu-
nobloting with a GFP antibody. As a positive control for binding to
Nup62N, we analyzed the binding of Kap β2 nuclear import
receptor to GST-Nup62N, by incubating HeLa cell lysate with
GST-Nup62N, GST-Nup62C, or GST and the bound proteins were
analyzed by immunobloting with a Kap β2 antibody.
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